What does pharma need to know about the proposed major EU legislation changes affecting our industry?
Join Ed Corbett, our Head of Consulting, and Anne-Sophie Lenoir, Director in our Berlin office, to explore:
- The proposed changes
- The implications for pharma
- What companies need to do today to ensure future success
The proposed changes touch on everything from access to medicines to novel antibiotics and the EMA, the EU’s pharma regulator, and look set to have a profound impact on the pharmaceutical industry across the globe.
The changes would be the first major overhaul of EU pharma regulations for 20 years, and could have a huge impact on the worldwide pharma industry – so don’t miss out!
Click here to watch.